In the News

1851 News Items found
Pictured: Charles Sawyers
Honors
Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.
Pictured: Neurons
In the Lab
Researchers have clarified the process by which developing nerve cells are directed to specialize into distinct parts.
Pictured: X-ray Image
In the Lab
Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
Pictured: Ming Li
Q&A
Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
Pictured: Michel Sadelain & Jedd Wolchok
Announcement
Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.
Pictured: Lorenz Studer
Q&A
Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.
Pictured: Charles Sawyers
Announcement
Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.
Pictured: 2012 Rock Stars of Science
Announcement
The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.
Pictured: Scott Lowe
Q&A
In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.
Pictured: PET Scan
In the Lab
Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.